These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16238829)

  • 21. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
    Leclercq P; Blanc M
    Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoatrophy: a new "scarlet letter".
    Hoyt G
    Surviv News (Atlanta Ga); 2004; 15(2):8, 19. PubMed ID: 15124576
    [No Abstract]   [Full Text] [Related]  

  • 23. Dyslipidaemia and cardiovascular risk in HIV infection.
    Kulasekaram R; Peters BS; Wierzbicki AS
    Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic toxicities and HIV.
    McGuire S
    Posit Aware; 2002; 13(6):23-5. PubMed ID: 12484331
    [No Abstract]   [Full Text] [Related]  

  • 25. Complications & side effects. Can TH9057 reduce fat deposits?
    TreatmentUpdate; 2004; 16(7):3. PubMed ID: 17219684
    [No Abstract]   [Full Text] [Related]  

  • 26. Osteoporosis and HIV disease.
    Cheonis N
    BETA; 2001; 14(2):26-34. PubMed ID: 11785482
    [No Abstract]   [Full Text] [Related]  

  • 27. New guidelines on metabolic complications of HIV and antiretroviral treatment.
    AIDS Treat News; 2002 Nov; (385):2. PubMed ID: 12492037
    [No Abstract]   [Full Text] [Related]  

  • 28. Editorial comment: reversing lipoatrophy--better solutions needed.
    McComsey G
    AIDS Read; 2004 Dec; 14(12):648-9. PubMed ID: 15619780
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV and HIV treatment: effects on fats, glucose and lipids.
    Gkrania-Klotsas E; Klotsas AE
    Br Med Bull; 2007; 84():49-68. PubMed ID: 17981955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical perspectives on HIV-associated lipodystrophy syndrome: an update.
    Shevitz A; Wanke CA; Falutz J; Kotler DP
    AIDS; 2001 Oct; 15(15):1917-30. PubMed ID: 11600819
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lipodystrophy in HIV infected children].
    Popielska J
    Pol Merkur Lekarski; 2008 May; 24(143):408-13. PubMed ID: 18634383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy.
    Palacios R; Merchante N; Macias J; González M; Castillo J; Ruiz J; Márquez M; Gómez-Mateos J; Pineda JA; Santos J
    Antivir Ther; 2006; 11(4):529-35. PubMed ID: 16856627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What does the term "HIV-associated lipodystrophy" mean?
    Marcason W
    J Am Diet Assoc; 2009 Feb; 109(2):364. PubMed ID: 19167963
    [No Abstract]   [Full Text] [Related]  

  • 34. Update from the 3rd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV.
    Cofrancesco J
    Hopkins HIV Rep; 2002 Jan; 14(1):6-7, 12. PubMed ID: 11851123
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-HIV agents. Switching therapy may help reverse body shape changes.
    TreatmentUpdate; 2004 Jan; 16(1):1-3. PubMed ID: 17216830
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipodystrophy: no answers emerge in Durban.
    Pieribone D
    Posit Living; 2000 Aug; 9(7):19, 27. PubMed ID: 12492028
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy.
    Hartman K; Verweel G; de Groot R; Hartwig NG
    Pediatr Infect Dis J; 2006 May; 25(5):427-31. PubMed ID: 16645507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone disease and HIV infection.
    Rojo P; Ramos JT
    Clin Infect Dis; 2006 Jul; 43(1):111-2; author reply 113-4. PubMed ID: 16758430
    [No Abstract]   [Full Text] [Related]  

  • 39. Vertebral fractures in AIDS patients within 6 months from highly active antiretroviral therapy initiation: two case reports.
    Gazzola L; Bini T; Pietrogrande L; Uziel L; Cicconi P; Casana M; Monforte Ad
    AIDS; 2008 May; 22(9):1094-7. PubMed ID: 18520358
    [No Abstract]   [Full Text] [Related]  

  • 40. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.
    Sevastianova K; Sutinen J; Kannisto K; Hamsten A; Ristola M; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E85-91. PubMed ID: 18430964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.